Deerfield Management Company, L.P. (Series C) Rx Sight, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $3.95 Billion
- Q1 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Rx Sight, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 392,332 shares of RXST stock, worth $5.24 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
392,332Holding current value
$5.24 Million% of portfolio
0.25%Shares
5 transactions
Others Institutions Holding RXST
# of Institutions
203Shares Held
34.5MCall Options Held
269KPut Options Held
8.5K-
Ra Capital Management, L.P. Boston, MA3.74MShares$50 Million1.96% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$32 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.39MShares$31.9 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.18MShares$29.2 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.77MShares$23.6 Million0.08% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $369M
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...